Total Debt of Approx. 17.6 Billion Yen, the Largest in 10 Years; Bankrupt Companies in Kumamoto Prefecture in 2025 Include “Kumamoto Kanko Kaihatsu,” “AT Seisan Kaisha,” and “Miyokikai Medical Corporation” – TBS NEWS DIG

News Highlights

The total debt of bankrupt companies in Kumamoto Prefecture in 2025 reached approximately 17.6 billion yen, the largest in the past 10 years. Notably, Miyokikai Medical Corporation is included in this list, drawing attention to its financial situation, which suggests the importance of regional healthcare stability and business succession.

M&A Medical Editorial Department’s Perspective

The bankruptcy of Miyokikai Medical Corporation with a massive debt of approximately 17.6 billion yen highlights the severe challenges in managing medical institutions in Kumamoto Prefecture. The scale, being the largest in the past decade, raises concerns not only about the individual corporation but also about its impact on the regional healthcare delivery system. Had they initiated management improvements or considered business succession earlier, perhaps at the first signs of deteriorating current ratios or consecutive years of operating losses, options like M&A could have facilitated negotiations to release the director’s personal joint guarantee and ensured a smooth handover to patients and staff. While the specific circumstances leading to Miyokikai’s debt of this magnitude remain unclear, this news serves as a stark reminder to healthcare facility managers facing similar risks that action is needed not in the hypothetical “what if” scenario, but “now.”

Key Issues Highlighted by This News

• The fact that Miyokikai Medical Corporation went bankrupt with a total debt of approximately 17.6 billion yen indicates a serious situation in the management of medical institutions in Kumamoto Prefecture.
• The debt amount, the largest in the past 10 years, signifies the potential impact on the regional healthcare delivery system.
• Early analysis of the management situation and consultation with experts are essential to avoid the worst-case scenario of bankruptcy.
• M&A conducted under sound financial conditions leaves room for negotiation, such as the release of personal guarantees for management and the maintenance of employment for patients and staff.

Practical Questions Arising from This News

• What circumstances led Miyokikai Medical Corporation to accumulate debt amounting to approximately 17.6 billion yen?
• What potential impact could Miyokikai’s bankruptcy have on the management of other medical institutions in Kumamoto Prefecture?
• How will patients and staff be affected by the closure of Miyokikai Medical Corporation?

“Should I Consult Too?” If You Feel This Way

If your clinic has seen a decline in operating profit margins or a decrease in liquid assets in recent years, the case of Miyokikai Medical Corporation is not an isolated incident. Before reaching the point of closure, consulting with experts in M&A and business succession early on can help you map out the best path tailored to your clinic’s situation and minimize risks for the management. Let’s start by understanding your current situation.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are handled with strict confidentiality. Free consultations are available here.